News | April 21, 2008

Cancer Cells Exploiting Master Control Genes Causes Metastases

April 22, 2008 - Tumor metastasis is caused by cancer cells that exploit a small number of master control genes, according to research delivered by the keynote speaker, Robert Weinberg, M.D., Whitehead Institute for Biomedical Research, Cambridge, MA, at the opening of the International Conference on 'Invasion and Metastasis' in Berlin, Germany.

"The process of tumor metastasis has until recently been one of bewildering complexity. However, one can now begin to rationalize this complex process in terms of a relatively small number of master control genes which normally operate during normal development and which are appropriated and exploited by cancer cells," Dr. Weinberg said.

The reason for this is the discovery of transcription factors in the last few years. Transcription factors are proteins that turn genes on and off and can act to program many of the traits of highly malignant cells, as described by Dr. Weinberg, who is also a Professor at the Massachusetts Institute of Technology (MIT).

In 2007, almost 560,000 Americans and more than 1,8 million Europeans died of cancer, according to the American Cancer Society. "The vast majority (90 percent) of these patients were struck down by metastases, cancer cells that have disseminated and colonized in organs far from the primary tumor," Dr. Weinberg pointed out. "Only ten percent of cancer patients die of their primary tumors."

The majority of life-threatening cancers about 80 percent, occur in epithelial tissue. But what exactly enables cancer cells to leave the primary tumor and travel by the body's highways - the blood and the lymphatic vessels,as Dr. Weinberg put it, to seek new sites where they may found new colonies, is still uncertain.

Recent research suggests that a drastic alteration of the primary cancer cells (called epithelial- mesenchymal transition or EMT) plays a crucial role in this complex biological process. "The EMT involves a profound change in the biological phenotype of cells in which they shed their epithelial traits together with their gene expression pattern and acquire mesenchymal ones instead," Dr. Weinberg explained.

Special epithelial markers, like E-cadherin and beta-Catenin, are depressed. These markers normally keep the epithelial cells tightly together. The mesenchymal state frees these cells to move about and to invade other tissues, and also makes them resistant to apoptosis, programmed cell death. "This pathological process is strikingly similar to the EMT normally occurring during embryogenesis and wound healing," said Dr. Weinberg.

EMT is an important program, which enables carcinoma cells to become mobile and invasive. "Nonetheless, it is still unclear whether EMT underlies the malignant behavior of all carcinoma cells or whether alternative programs are activated to enable metastatic dissemination," Dr. Weinberg said.

For more information: http://www.wi.mit.edu/research/faculty/weinberg.html

Related Content

Technology | PACS Accessories | January 03, 2018
January 3, 2018 — medQ Inc. recently announced the launch of its Q/ris MIPS Reporting module.
Philips Expands Population Health Management Business With Acquisition of VitalHealth
News | Population Health | December 28, 2017
Philips recently announced that it acquired VitalHealth, a provider of cloud-based population health management...
News | Enterprise Imaging | December 21, 2017
Vital Images showcased enhancements to its enterprise imaging solutions at the Radiological Society of North America (...
Philips IntelliSpace Portal 10 Highlighted by New 3-D Modeling Application
Technology | Advanced Visualization | December 13, 2017
Philips announced the debut of IntelliSpace Portal 10, the latest edition of its comprehensive, advanced visualization...
Medexprim's Radiomics Enabler Goes Open Source
Technology | PACS Accessories | December 06, 2017
December 6, 2017 — Medexprim announced its Radiomics Enabler, meant to enhance medical images archives for research,
Ikonopedia and Konica Minolta Showcase Integrated Breast Imaging Workflow and Reporting at RSNA
News | Breast Imaging | December 05, 2017
Ikonopedia and Konica Minolta Healthcare Americas Inc. showcased integrated breast imaging workflow and reporting at...
Ambra Health Joins Google Cloud Technology Partner Program
News | PACS Accessories | December 05, 2017
December 4, 2017 — Ambra Health recently announced a new relationship with Google Cloud.
Fujifilm Introduces Artificial Intelligence Initiative for U.S. Market at RSNA 2017
News | Artificial Intelligence | December 04, 2017
December 4, 2017 — Fujifilm Medical Systems U.S.A. Inc.
Change Healthcare and Zebra Medical Vision Bring Artificial Intelligence to Medical Imaging
News | Artificial Intelligence | December 04, 2017
December 4, 2017 — Change Healthcare and Zebra Medical Vision announced an agreement to create solutions that deliver
ScImage Announces PicomPassport
Technology | PACS Accessories | November 30, 2017
ScImage Inc. introduced PicomPassport at the Radiological Society of North America’s 103rd Annual Scientific Assembly,...
Overlay Init